Cargando…

Development and validation of a metabolite index for obstructive sleep apnea across race/ethnicities

Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent episodes of upper airway obstruction during sleep resulting in oxygen desaturation and sleep fragmentation, and associated with increased risk of adverse health outcomes. Metabolites are being increasingly used for biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying, Ngo, Debby, Yu, Bing, Shah, Neomi A., Chen, Han, Ramos, Alberto R., Zee, Phyllis C., Tracy, Russell, Durda, Peter, Kaplan, Robert, Daviglus, Martha L., Rich, Stephen S., Rotter, Jerome I., Cai, Jianwen, Clish, Clary, Gerszten, Robert, Kristal, Bruce S., Gharib, Sina A., Redline, Susan, Sofer, Tamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758170/
https://www.ncbi.nlm.nih.gov/pubmed/36526671
http://dx.doi.org/10.1038/s41598-022-26321-9
_version_ 1784851985489461248
author Zhang, Ying
Ngo, Debby
Yu, Bing
Shah, Neomi A.
Chen, Han
Ramos, Alberto R.
Zee, Phyllis C.
Tracy, Russell
Durda, Peter
Kaplan, Robert
Daviglus, Martha L.
Rich, Stephen S.
Rotter, Jerome I.
Cai, Jianwen
Clish, Clary
Gerszten, Robert
Kristal, Bruce S.
Gharib, Sina A.
Redline, Susan
Sofer, Tamar
author_facet Zhang, Ying
Ngo, Debby
Yu, Bing
Shah, Neomi A.
Chen, Han
Ramos, Alberto R.
Zee, Phyllis C.
Tracy, Russell
Durda, Peter
Kaplan, Robert
Daviglus, Martha L.
Rich, Stephen S.
Rotter, Jerome I.
Cai, Jianwen
Clish, Clary
Gerszten, Robert
Kristal, Bruce S.
Gharib, Sina A.
Redline, Susan
Sofer, Tamar
author_sort Zhang, Ying
collection PubMed
description Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent episodes of upper airway obstruction during sleep resulting in oxygen desaturation and sleep fragmentation, and associated with increased risk of adverse health outcomes. Metabolites are being increasingly used for biomarker discovery and evaluation of disease processes and progression. Studying metabolomic associations with OSA in a diverse community-based cohort may provide insights into the pathophysiology of OSA. We aimed to develop and replicate a metabolite index for OSA and identify individual metabolites associated with OSA. We studied 219 metabolites and their associations with the apnea hypopnea index (AHI) and with moderate-severe OSA (AHI ≥ 15) in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) (n = 3507) using two methods: (1) association analysis of individual metabolites, and (2) least absolute shrinkage and selection operator (LASSO) regression to identify a subset of metabolites jointly associated with OSA, which was used to develop a metabolite index for OSA. Results were validated in the Multi-Ethnic Study of Atherosclerosis (MESA) (n = 475). When assessing the associations with individual metabolites, we identified seven metabolites significantly positively associated with OSA in HCHS/SOL (FDR p < 0.05), of which four associations—glutamate, oleoyl-linoleoyl-glycerol (18:1/18:2), linoleoyl-linoleoyl-glycerol (18:2/18:2) and phenylalanine, were replicated in MESA (one sided-p < 0.05). The OSA metabolite index, composed of 14 metabolites, was associated with a 50% increased risk for moderate-severe OSA (OR = 1.50 [95% CI 1.21–1.85] per 1 SD of OSA metabolite index, p < 0.001) in HCHS/SOL and 55% increased risk (OR = 1.55 [95% CI 1.10–2.20] per 1 SD of OSA metabolite index, p = 0.013) in MESA, both adjusted for demographics, lifestyle, and comorbidities. Similar albeit less significant associations were observed for AHI. Replication of the metabolite index in an independent multi-ethnic dataset demonstrates the robustness of metabolomic-based OSA index to population heterogeneity. Replicated metabolite associations may provide insights into OSA-related molecular and metabolic mechanisms.
format Online
Article
Text
id pubmed-9758170
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-97581702022-12-18 Development and validation of a metabolite index for obstructive sleep apnea across race/ethnicities Zhang, Ying Ngo, Debby Yu, Bing Shah, Neomi A. Chen, Han Ramos, Alberto R. Zee, Phyllis C. Tracy, Russell Durda, Peter Kaplan, Robert Daviglus, Martha L. Rich, Stephen S. Rotter, Jerome I. Cai, Jianwen Clish, Clary Gerszten, Robert Kristal, Bruce S. Gharib, Sina A. Redline, Susan Sofer, Tamar Sci Rep Article Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent episodes of upper airway obstruction during sleep resulting in oxygen desaturation and sleep fragmentation, and associated with increased risk of adverse health outcomes. Metabolites are being increasingly used for biomarker discovery and evaluation of disease processes and progression. Studying metabolomic associations with OSA in a diverse community-based cohort may provide insights into the pathophysiology of OSA. We aimed to develop and replicate a metabolite index for OSA and identify individual metabolites associated with OSA. We studied 219 metabolites and their associations with the apnea hypopnea index (AHI) and with moderate-severe OSA (AHI ≥ 15) in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) (n = 3507) using two methods: (1) association analysis of individual metabolites, and (2) least absolute shrinkage and selection operator (LASSO) regression to identify a subset of metabolites jointly associated with OSA, which was used to develop a metabolite index for OSA. Results were validated in the Multi-Ethnic Study of Atherosclerosis (MESA) (n = 475). When assessing the associations with individual metabolites, we identified seven metabolites significantly positively associated with OSA in HCHS/SOL (FDR p < 0.05), of which four associations—glutamate, oleoyl-linoleoyl-glycerol (18:1/18:2), linoleoyl-linoleoyl-glycerol (18:2/18:2) and phenylalanine, were replicated in MESA (one sided-p < 0.05). The OSA metabolite index, composed of 14 metabolites, was associated with a 50% increased risk for moderate-severe OSA (OR = 1.50 [95% CI 1.21–1.85] per 1 SD of OSA metabolite index, p < 0.001) in HCHS/SOL and 55% increased risk (OR = 1.55 [95% CI 1.10–2.20] per 1 SD of OSA metabolite index, p = 0.013) in MESA, both adjusted for demographics, lifestyle, and comorbidities. Similar albeit less significant associations were observed for AHI. Replication of the metabolite index in an independent multi-ethnic dataset demonstrates the robustness of metabolomic-based OSA index to population heterogeneity. Replicated metabolite associations may provide insights into OSA-related molecular and metabolic mechanisms. Nature Publishing Group UK 2022-12-16 /pmc/articles/PMC9758170/ /pubmed/36526671 http://dx.doi.org/10.1038/s41598-022-26321-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zhang, Ying
Ngo, Debby
Yu, Bing
Shah, Neomi A.
Chen, Han
Ramos, Alberto R.
Zee, Phyllis C.
Tracy, Russell
Durda, Peter
Kaplan, Robert
Daviglus, Martha L.
Rich, Stephen S.
Rotter, Jerome I.
Cai, Jianwen
Clish, Clary
Gerszten, Robert
Kristal, Bruce S.
Gharib, Sina A.
Redline, Susan
Sofer, Tamar
Development and validation of a metabolite index for obstructive sleep apnea across race/ethnicities
title Development and validation of a metabolite index for obstructive sleep apnea across race/ethnicities
title_full Development and validation of a metabolite index for obstructive sleep apnea across race/ethnicities
title_fullStr Development and validation of a metabolite index for obstructive sleep apnea across race/ethnicities
title_full_unstemmed Development and validation of a metabolite index for obstructive sleep apnea across race/ethnicities
title_short Development and validation of a metabolite index for obstructive sleep apnea across race/ethnicities
title_sort development and validation of a metabolite index for obstructive sleep apnea across race/ethnicities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758170/
https://www.ncbi.nlm.nih.gov/pubmed/36526671
http://dx.doi.org/10.1038/s41598-022-26321-9
work_keys_str_mv AT zhangying developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT ngodebby developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT yubing developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT shahneomia developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT chenhan developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT ramosalbertor developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT zeephyllisc developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT tracyrussell developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT durdapeter developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT kaplanrobert developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT daviglusmarthal developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT richstephens developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT rotterjeromei developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT caijianwen developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT clishclary developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT gersztenrobert developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT kristalbruces developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT gharibsinaa developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT redlinesusan developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities
AT sofertamar developmentandvalidationofametaboliteindexforobstructivesleepapneaacrossraceethnicities